E
E. Kiss
Researcher at Semmelweis University
Publications - 23
Citations - 925
E. Kiss is an academic researcher from Semmelweis University. The author has contributed to research in topics: Lupus erythematosus & Vitamin D and neurology. The author has an hindex of 7, co-authored 21 publications receiving 862 citations.
Papers
More filters
Journal ArticleDOI
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?
Howard Amital,Zoltán Szekanecz,Gabriella Szücs,Katalin Dankó,Endre Nagy,Tünde Csépány,E. Kiss,Jozef Rovensky,A. Tuchynova,Darina Kozakova,Andrea Doria,N. Corocher,Nancy Agmon-Levin,Vivian Barak,Hedi Orbach,Gisele Zandman-Goddard,Yehuda Shoenfeld +16 more
TL;DR: In a cohort of patients with SLE originating from Israel and Europe vitamin D serum concentrations were found to be inversely related to disease activity.
Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
Ricard Cervera,Ma. Khamashta,Y Shoenfeld,Mt Camps,S Jacobsen,E. Kiss,Mm Zeher,Angela Tincani,I. Kontopoulou Griva,Mauro Galeazzi,Francesca Bellisai,Pl Meroni,Rh Derksen,Pg Groot,E. Gromnica Ihle,Marta Baleva,Marta Mosca,Stefano Bombardieri,F. Houssiau,J-C Gris,Isabelle Quéré,E. Hachulla,Carlos Vasconcelos,B. Roch,A. Fernández Nebro,J-C Piette,Gerard Espinosa,Silvia Bucciarelli,Cn Pisoni,M L Bertolaccini,M C Boffa,G. R. V. Hughes +31 more
Abstract: Objectives: To identify the main causes of morbidity and mortality in patients with antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and immunological parameters with prognostic significance. Methods: The clinical and immunological features of a cohort of 1000 patients with APS from 13 European countries who had been followed up from 1999 to 2004 were analysed. Results: 200 (20%) patients developed APS-related manifestations during the 5-year study period. Recurrent thrombotic events appeared in 166 (16.6%) patients and the most common were strokes (2.4% of the total cohort), transient ischaemic attacks (2.3%), deep vein thromboses (2.1%) and pulmonary embolism (2.1%). When the thrombotic events occurred, 90 patients were receiving oral anticoagulants and 49 were using aspirin. 31/420 (7.4%) patients receiving oral anticoagulants presented with haemorrhage. 3/121 (2.5%) women with only obstetric APS manifestations at the start of the study developed a new thrombotic event. A total of 77 women (9.4% of the female patients) had one or more pregnancies and 63 (81.8% of pregnant patients) had one or more live births. The most common fetal complications were early pregnancy loss (17.1% of pregnancies) and premature birth (35% of live births). 53 (5.3% of the total cohort) patients died. The most common causes of death were bacterial infection (21% of deaths), myocardial infarction (19%) and stroke (13%). No clinical or immunological predictor of thrombotic events, pregnancy morbidity or mortality was detected. Conclusion: Patients with APS still develop significant morbidity and mortality despite current treatment (oral anticoagulants or antiaggregants, or both).
Journal ArticleDOI
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period
Ricard Cervera,Munther A. Khamashta,Y Shoenfeld,M. T. Camps,S Jacobsen,E. Kiss,Margit Zeher,Angela Tincani,I. Kontopoulou-Griva,Mauro Galeazzi,Francesca Bellisai,Pl Meroni,R. H. W. M. Derksen,de Peter Groot,Erika Gromnica-Ihle,Marta Baleva,Marta Mosca,Stefano Bombardieri,F. Houssiau,J-C Gris,Isabelle Quéré,Eric Hachulla,Carlos Vasconcelos,B. Roch,Antonio Fernández-Nebro,J-C Piette,Gerard Espinosa,Silvia Bucciarelli,Cecilia N. Pisoni,Maria Laura Bertolaccini,M C Boffa,G. R. V. Hughes +31 more
TL;DR: Patients with APS still develop significant morbidity and mortality despite current treatment (oral anticoagulants or antiaggregants, or both), according to this 5-year study.
Journal ArticleDOI
The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary.
TL;DR: The data suggest that vitamin D deficiency in SLE may play a role in perpetuation of the disease and serological and clinical parameters in patients with different vitamin D levels from a single centre registry in Central-Eastern Europe.
Journal ArticleDOI
The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
TL;DR: Several cognitive functions measured by CANTAB are negatively influenced by hyperphenylalaninemia in adult PKU patients, however, response speed and initial thinking time were not impaired as seriously as other functions.